Mosqitter Transforms Mosquito Traps Into AI-Powered Disease Surveillance Network

The Growing Mosquito Crisis

Mosquito-borne diseases are spreading at alarming rates as climate change and global travel reshape where disease-carrying insects can survive. The World Health Organization reported dengue cases more than doubled in a single year, climbing from 6.5 million globally in 2023 to 14.6 million in 2024. Rising temperatures and shifting rainfall patterns are expanding the geographic range where dangerous mosquitoes can establish populations, creating urgent demand for better monitoring and control solutions.

Mosqitter's Hardware Foundation

A 30-person Pennsylvania startup called Mosqitter has built its business on chemical-free mosquito traps that mimic human signals to attract and capture female mosquitoes—the only ones that bite. The devices use heat mimicking human skin temperature, scent imitating human odor, and in the company's premium Grand model, carbon dioxide to replicate human breathing. Co-founder and CEO Anastasiia Romanova explained the strategic timing: female mosquitoes seek blood before laying eggs on roughly three-week cycles, producing 100 to 200 eggs at a time. By capturing females at this vulnerable moment, the traps can suppress population growth before it accelerates. The company has grown significantly since its 2021 launch, expanding from 250 devices in 2022 to more than 5,000 operating across five continents.

AI-Powered Species Identification

Mosqitter's next-generation capability leverages artificial intelligence to identify mosquito species from trapped insects. The company's computer-vision system analyzes biological characteristics through a neural network, cross-references findings against external datasets, and validates results with entomologists before assigning a confidence score. Co-founder Olga Diachuk likened the process to three judges analyzing a case and producing a verdict. By identifying species rather than just counting insects, Mosqitter can provide early warnings about disease risks specific to particular mosquitoes—dengue-carrying varieties, for instance, present different threats than other species.

Febris Monitoring System and Government Partnerships

The company is launching its Febris Monitoring System next month, which layers environmental data including weather, wind, and humidity onto mosquito population data to forecast changes in mosquito numbers and associated disease risks. Importantly, Romanova clarified that Febris does not diagnose disease or confirm whether specific mosquitoes carry pathogens. Instead, it flags when disease-capable species appear in particular locations, allowing governments and health agencies to assess increased risk. The system targets institutional buyers including government agencies, public-health departments, airports, municipalities, and universities seeking continuous monitoring. Mosqitter is already piloting Febris at Heathrow and Gatwick airports in partnership with the United Kingdom Health Security Agency, recognizing that international travel hubs require vigilant mosquito surveillance.

Market Expansion and Revenue Model

Mosqitter pursues different sales strategies across key markets. In the United States, the company sells its $199 Mini device directly to consumers via Amazon and its website. In Greece, it partners with an established pest-control company. Brazil, which carries a high dengue burden, now hosts local Mosqitter manufacturing and sales operations. The company also targets the United States, India, Ukraine, and Nigeria as core markets. The Mosqitter Mini retails for $199 while the professional Grand system costs $1,999. The startup generates revenue from hardware sales, with Febris adding a recurring revenue stream from monitoring services, dashboards, analytics, and data products. Mosqitter projected more than $1 million in total revenue for 2026, with Febris expected to contribute over $3.5 million next year based on current contract bids.

Funding and Growth Trajectory

The startup is raising a $5 million funding round split into two tranches—$1 million initially followed by $4 million tied to Febris milestones. To date, Mosqitter has raised $1.9 million. The two-tranche structure reflects the company's staged rollout of its monitoring system. As mosquito-borne diseases expand geographically and governments prioritize disease surveillance infrastructure, Romanova emphasized that the Febris business could grow substantially since governments are major buyers of mosquito-surveillance data. The company's evolution from hardware-focused mosquito control to a data-driven surveillance platform positions it at the intersection of climate adaptation and public health.